Search Results - "Sandler, A B"

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer by Soria, J.-C., Mauguen, A., Reck, M., Sandler, A.B., Saijo, N., Johnson, D.H., Burcoveanu, D., Fukuoka, M., Besse, B., Pignon, J.-P.

“…Previous studies have demonstrated the efficacy and safety of bevacizumab in the treatment of non-small-cell lung cancer (NSCLC). Summary data from randomised…”
Get full text

Baseline tumour measurements predict survival in advanced non-small cell lung cancer by Gerber, D E, Dahlberg, S E, Sandler, A B, Ahn, D H, Schiller, J H, Brahmer, J R, Johnson, D H

“…Background: The association between tumour measurements and survival has been studied extensively in early-stage and locally advanced non-small cell lung…”
Get full text

Differential effect of age on survival in advanced NSCLC in women versus men: Analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab by Wakelee, H.A, Dahlberg, S.E, Brahmer, J.R, Schiller, J.H, Perry, M.C, Langer, C.J, Sandler, A.B, Belani, C.P, Johnson, D.H

“…Abstract Background The impact of age on prognosis in advanced stage non-small cell lung cancer (NSCLC) may differ by sex. Patients and methods Eligible…”
Get full text

Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer by SANDLER, A. B, NEMUNAITIS, J, NGUYEN, B, NIYIKIZA, C, EINHORN, L. H, DENHAM, C, VON PAWEL, J, CORMIER, Y, GATZEMEIER, U, MATTSON, K, MANEGOLD, C, PALMER, M. C, GREGOR, A

“…The Hoosier Oncology Group has previously reported the results of its phase II trial of the combination of cisplatin plus gemcitabine. In that study of 27…”
Get full text

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies by ATKINS, M. B, ROBERTSON, M. J, MIER, J. W, CANNING, C. M, BATTIATO, L, TAHARA, H, SHERMAN, M. L, GORDON, M, LOTZE, M. T, DECOSTE, M, DUBOIS, J. S, RITZ, J, SANDLER, A. B, EDINGTON, H. D, GARZONE, P. D

“…A Phase I dose escalation trial of i.v. administered recombinant human interleukin 12 (rhIL-12) was performed to determine its toxicity, maximum tolerated dose…”
Get full text

Current management of small cell lung cancer by Sandler, A B

“…There will be approximately 45,000 new cases of small cell lung cancer (SCLC) this year. Despite the initial sensitivity to chemotherapy, only 10% of all SCLC…”
Get more information

Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study by HANNA, N. H, SANDLER, A. B, LOEHRER, P. J, ANSARI, R, JUNG, S. H, LANE, K, EINHORN, L. H

“…We performed this phase III study to determine whether the addition of 3 months of oral etoposide in non-progressing patients with extensive small-cell lung…”
Get full text

Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction by Sandler, A. B., Kindler, H. L., Einhorn, L. H., Mitchell, E., Masters, G., Kraut, M., Nicol, S., Raghavan, D.

“…Background: There were approximately 12,500 cases of esophageal carcinoma diagnosed in the US in 1992 and 12,200 deaths. The impact of chemotherapy on patients…”
Get full text

Role of computed tomography in the staging of primary melanoma by Buzaid, A C, Sandler, A B, Mani, S, Curtis, A M, Poo, W J, Bolognia, J L, Ariyan, S

“…To evaluate the role of body computed tomography (CT) for the staging of patients with early melanoma. A total of 151 new patients with American Joint…”
Get more information

Adenovirus early region 4 is essential for normal stability of late nuclear RNAs by SANDLER, A. B, KETNER, G

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

A phase II trial of paclitaxel in refractory germ cell tumors by Sandler, Alan B., Cristou, Antonios, Fox, Susan, Williams, Stephen D., Nichols, Craig R., Turns, Martine, Roth, Bruce J.

“…BACKGROUND A significant percentage of patients with refractory germ cell tumors will not respond to standard salvage regimens. Thus there is a need for new…”
Get full text

Narcissism and empathy in steroid users by Porcerelli, J H, Sandler, B A

“…In an effort to begin to construct a psychological profile of anabolic steroid users, the authors compared weight lifters and bodybuilders who did or did not…”
Get more information

Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer by Sandler, A B

“…Approximately 25% of all lung cancer cases diagnosed in 1993 were due to small cell lung cancer (SCLC). Approximately one third of all SCLC patients present…”
Get more information

Anabolic-androgenic steroid abuse and psychopathology by Porcerelli, J H, Sandler, B A

“…Anabolic steroid abuse is a significant public health problem. There is evidence from both case reports and empirical studies that abuse of these drugs causes…”
Get more information

Repression of bovine papillomavirus type 1 transcription by the E1 replication protein by Sandler, A.B, Vande Pol, S.B, Spalholz, B.A

“…Bovine papillomavirus type 1 (BPV-1) is the prototype virus for the study of papillomavirus gene regulation. The functions of the BPV-1 E2 proteins in…”
Get full text

A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC) : a hoosier oncology group study by NG, E. W, SANDLER, A. B, ROBINSON, L, EINHORN, L. H

“…The purpose of this study was to evaluate the toxicity and determine the response rate, duration of remission, and survival using gemcitabine plus carboplatin…”
Get full text

Phase I Trial of the Combination of Irinotecan, Paclitaxel, and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer by SOCINSKI, Mark A, SANDLER, Alan B, MILLER, Langdon L, LOCKER, Paula K, HANOVER, Cristy K, ELFRING, Gary L, ISRAEL, Valerie K, PIROTTA, Nicoletta, NATALE, Ronald B

“…To determine the maximum-tolerated dose, toxicities, and dose suitable for phase II/III trials of irinotecan (CPT-11) combined with paclitaxel and carboplatin…”
Get full text

The epidemiology of lung cancer by Williams, M D, Sandler, A B

“…Lung cancer continues to be the leader in cancer deaths in the United States. The incidence of lung cancer in men has slowly decreased since the late 1980s,…”
Get more information

Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial by Faylona, E A, Loehrer, P J, Ansari, R, Sandler, A B, Gonin, R, Einhorn, L H

“…The study was undertaken to determine the activity and toxicity of oral etoposide (VP-16), ifosfamide, and cisplatin combination chemotherapy for previously…”
Get more information

Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate cancer. Response to epsilon-aminocaproic acid by Cooper, D L, Sandler, A B, Wilson, L D, Duffy, T P

“…Disseminated intravascular coagulation (DIC) and primary fibrinolysis have both been reported in association with prostate carcinoma. The correct diagnosis of…”
Get more information